New research indicates that individuals who stop using new GLP-1 drugs like Mounjaro or Wegovy tend to recover shed pounds much more quickly than those who stop conventional lifestyle regimens.
Published data in a prominent health publication shows that while obese individuals frequently drop substantial amounts of their total mass while using the jabs, the mass returns at an estimated rate of 0.8 kg per month upon discontinuation.
"Users using such treatments need to be aware of the potential of quick rebound weight gain when the therapy is stopped," stated researcher Dr. Susan Jebb.
That rate of recovery suggests a reversion to starting mass in about a year and a half.
Comparing Treatments
The study, which examined 37 of studies involving thousands of participants, compared the outcomes of the injectable medications with older methods.
Researchers point out that individuals who shed pounds through dieting generally experience a more gradual weight regain—around 0.1 kg a month—once they finish.
The Reason for the Fast Rebound
Doctors suggest the mode of action of the jabs explains the amplified rebound.
The injections imitate a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Sustained high doses of GLP-1 concentrations far above than the body's typical production could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also diminish sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' means hunger is uncontrolled, making binge eating far more likely."
A Lifelong Issue?
Medical guidelines suggest the injections for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
Many experts contend that, considering the likelihood of relapse, the therapy should be considered long-term.
This perspective is reinforced by pharmaceutical companies, who state that the results "highlight the long-term nature of excess weight," similar to managing conditions like hypertension.
User Testimonies
Individuals who have come off the jabs describe a intense resurgence of cravings.
"I experienced a switch that goes on and you become extremely hungry," described an individual.
This challenge is worsened if patients have not established sustainable dietary or behavioural modifications during therapy.
Growing Interest
Recent estimates show that millions of people in the UK have tried weight-loss jabs in the past year, with demand continuing to grow.
- Use is higher among women compared to males.
- The middle-aged age group shows the greatest usage rates.
- Many access the drugs through private healthcare rather than the NHS.
In conclusion, researchers emphasize that while these medications are powerful tools for shedding pounds, they are not a permanent fix and maintained weight loss relies on integrated lifestyle management.
